LawGrids logoLAWGRIDS.ORG

Rule 6, Drugs (Prices Control) Order, 2013: Ceiling price of a scheduled formulation in case of no reduction in price due to absence of competition

Drugs (Prices Control) Order, 2013 - Rule 6

Text of rule 6

Ceiling price of a scheduled formulation in case of no reduction in price due to absence of competition

6. Ceiling price of a scheduled formulation in case of no reduction in price due to absence of competition.– (1) where the average price to retailer of a scheduled formulation, arrived at as per the formula specified in sub-paragraph (1) of paragraph 4, has the effect of,- (a) no reduction in average price to retailer with respect to the prices to retailer of the schedule formulation; and consider necessary and such manufacturer shall furnish the required information within such time the Government may fix. 4. Calculation of ceiling price of a scheduled formulation.-— (1) The ceiling price of a scheduled formulation of specified strengths and dosages as specified under the first schedule shall be calculated as under: Step1. First the Average Price to Retailer of the scheduled formulation i.e. P(s) shall be calculated as below: Average Price to Retailer, P(s) = (Sum of prices to retailer of all the brands and generic versions of the medicine having market share more than or equal to one percent of the total market turnover on the basis of moving annual turnover of that medicine) / (Total number of such brands and generic versions of the medicine having market share more than or equal to one percent of total market turnover on the basis of moving annual turnover for that medicine. ) Step2. Thereafter, the ceiling price of the scheduled formulation i.e. P(c) shall be calculated as below: P(c) = P(s).(1+M/100), where P(s) = Average Price to Retailer for the same strength and dosage of the medicine as calculated in step1 above. M = % Margin to retailer and its value =16 (2) The ceiling price calculated as per sub-paragraph (1) and notified by the Government shall be applicable to scheduled imported formulations also. 5. Calculation of retail price of a new drug for existing manufacturers of scheduled formulations.— (1) The retail price of the new drug available in domestic market shall be calculated as provided in sub-paragraph (1) of paragraph 4. (2) (i) the price to retailer of a new drug, not available in domestic market, shall be fixed by the Government on the principles of “Pharmacoeconomics” of the new drug, on the recommendation of a Standing Committee of Experts formed under paragraph 15. (ii) the retail price of such new drug shall be fixed by adding sixteen percent margin to retailer on the price to retailer as fixed in item (i): 6. Ceiling price of a scheduled formulation in case of no reduction in price due to absence of competition.— (1) where the average price to retailer of a scheduled formulation, arrived at as per the formula specified in sub-paragraph (1) of paragraph 4, has the effect of,- (a) no reduction in average price to retailer with respect to the prices to retailer of the schedule formulation; and (b) there are less than five manufacturers for that formulation having one percent or more market share, the ceiling price shall be calculated as under:- (i) in the event of other strengths or dosage forms of the same scheduled formulation is available in the list of scheduled formulation, the average price to retailer shall be calculated as under: Step1: First the Average Price to Retailer of such scheduled formulation i.e. P(s) shall be calculated as under: P(s) = Pm{1-(Pi1+Pi2+…)/(N*100)} Where, Pm = Price to Retailer of highest priced scheduled formulation under consideration. Pi = % reduction in Average Price to Retailer of other strengths and dosage forms (calculated as in step1 of sub-paragraph (1) of paragraph 4) in the list of schedule formulations w.r.t the highest priced formulation taken for calculating the average price to retailer of such strengths and dosage forms. N = Number of such other strengths or dosage forms or both in the list of schedule formulations Step2. Thereafter, the ceiling price of the scheduled formulation i.e. P(c) shall be calculated as under: P(c) = P(s).(1+M/100), where P(s) = Average Price to Retailer of the scheduled formulation as calculated in step1 hereinabove and M = % Margin to retailer and its value=16 (ii) in the event of other strengths or dosage forms of the scheduled formulation is not available in the schedule but there are other scheduled formulations in same sub-therapeutic category as that of the scheduled formulation, then the Ceiling Price shall be calculated as under: Step1: First the Average Price to Retailer of such scheduled formulation i.e. P(s) shall be calculated as under: P(s) = Pm{1-(Pi1+Pi2+…)/(N*100)}, Where, Pm = Price of highest priced formulation taken for calculating the average price to retailer of the formulation under consideration.. Pi = % reduction in Average Price to Retailer of other schedule formulations (calculated as in step1 of sub-paragraph (1) of paragraph 4) in same sub-therapeutic category as that of the scheduled formulation under consideration w.r.t the highest priced formulation taken for calculating the average price to retailer. N = Number of such other schedule formulations in same sub- therapeutic category as that of the scheduled formulation under consideration. (b) there are less than five manufacturers for that formulation having one percent or more market share, the ceiling price shall be calculated as under:- (i) in the event of other strengths or dosage forms of the same scheduled formulation is available in the list of scheduled formulation, the average price to retailer shall be calculated as under: Stepi1: First the Average Price to Retailer of such scheduled formulation i.e. P(s) shall be calculated as under: P(s) = Pm{1-(Pi1+Pi2+...)/(N*100)} Where, Pm = Price to Retailer of highest priced scheduled formulation under consideration. Pi = % reduction in Average Price to Retailer of other strengths and dosage forms (calculated as in step1 of sub-paragraph (1) of paragraph 4) in the list of schedule formulations w.r.t the highest priced formulation taken for calculating the average price to retailer of such strengths and dosage forms. N = Number of such other strengths or dosage forms or both in the list of schedule formulations Step2. Thereafter, the ceiling price of the scheduled formulation i.e. P(c) shall be calculated as under: P(c) = P(s).(1+M/100), where P(s) = Average Price to Retailer of the scheduled formulation as calculated in step1 hereinabove and M = % Margin to retailer and its value=16 (ii) in the event of other strengths or dosage forms of the scheduled formulation is not available in the schedule but there are other scheduled formulations in same sub-therapeutic category as that of the scheduled formulation, then the Ceiling Price shall be calculated as under: Stepi1: First the Average Price to Retailer of such scheduled formulation i.e. P(s) shall be calculated as under: P(s) = Pm{1-(Pi1+Pi2+...)/(N*100)}, Where, Pm = Price of highest priced formulation taken for calculating the average price to retailer of the formulation under consideration.. Pi = % reduction in Average Price to Retailer of other schedule formulations (calculated as in step1l of sub-paragraph (1) of paragraph 4) in same sub-therapeutic category as that of the scheduled formulation under consideration w.r.t the highest priced formulation taken for calculating the average price to retailer. N = Number of such other schedule formulations in same sub- therapeutic category as that of the scheduled formulation under consideration. Step2. Thereafter, the ceiling price of the scheduled formulation i.e. P(c) shall be calculated as under: P(c) = P(s)*(1+M/100), where P(s) = Average Price to Retailer of the scheduled formulation as calculated in step1 above and M = % Margin to retailer and its value=16 Explanation.- where the scheduled formulation under consideration is coming under more than one sub-therapeutic category, the Average Price to Retailer of the scheduled formulation shall be calculated after taking into consideration the percentage reduction in Average Price to Retailer of other schedule formulations under all such sub-therapeutic categories and the lowest average price to retailer shall be taken for calculating the ceiling price of the scheduled formulation under consideration; (iii) in case the other strengths or dosage forms of the scheduled formulation are not available in the schedule and there is no sub therapeutic category of the scheduled under consideration, the ceiling price shall be calculated as under: Step1: First the Average Price to Retailer of such scheduled formulation i.e. P(s) shall be calculated as under: P(s) = Pm{1-(Pi1+Pi2+…)/(N*100)} Where, Pm = Price of highest priced formulation taken for calculating the average price to retailer of the formulation under consideration. Pi = % reduction in Average Price to Retailer of other schedule formulations (calculated as in step1 sub-paragraph (1) of paragraph 4) in same therapeutic category as that of the scheduled formulation under consideration w.r.t the highest priced formulation taken for calculating the average price to retailer. N = Number of such other schedule formulations in same therapeutic category as that of the scheduled formulation under consideration. Step2. Thereafter, the ceiling price of the scheduled formulation i.e. P(c) shall be calculated as under: P(c) = P(s).(1+M/100), where P(s) = Average Price to Retailer of the scheduled formulation as calculated in step1 above and M = % Margin to retailer and its value=16 Explanation.- where the scheduled formulation under consideration is coming under more than one therapeutic category, the Average Price to Retailer of the scheduled formulation shall be calculated after taking into consideration the percentage reduction in Average Price to Retailer of other schedule formulations under all such therapeutic categories and the lowest average price to retailer shall Step2. Thereafter, the ceiling price of the scheduled formulation i.e. P(c) shall be calculated as under: P(c) = P(s)*(1+M/100), where P(s) = Average Price to Retailer of the scheduled formulation as calculated in step1 above and M = % Margin to retailer and its value=16 Explanation.- where the scheduled formulation under consideration is coming under more than one sub-therapeutic category, the Average Price to Retailer of the scheduled formulation shall be calculated after taking into consideration the percentage reduction in Average Price to Retailer of other schedule formulations under all such sub-therapeutic categories and the lowest average price to retailer shall be taken for calculating the ceiling price of the scheduled formulation under consideration; (iii) in case the other strengths or dosage forms of the scheduled formulation are not available in the schedule and there is no sub therapeutic category of the scheduled under consideration, the ceiling price shall be calculated as under: Stepi: First the Average Price to Retailer of such scheduled formulation i.e. P(s) shall be calculated as under: P(s) = Pm{1-(Pi1+Pi2+...)/(N*100)} Where, Pm = Price of highest priced formulation taken for calculating the average price to retailer of the formulation under consideration. Pi = % reduction in Average Price to Retailer of other schedule formulations (calculated as in step1 sub-paragraph (1) of paragraph 4) in same therapeutic category as that of the scheduled formulation under consideration w.r.t the highest priced formulation taken for calculating the average price to retailer. N = Number of such other schedule formulations in same therapeutic category as that of the scheduled formulation under consideration. Step2. Thereafter, the ceiling price of the scheduled formulation i.e. P(c) shall be calculated as under: P(c) = P(s).(1+M/100), where P(s) = Average Price to Retailer of the scheduled formulation as calculated in step1 above and M = % Margin to retailer and its value=16 Explanation.- where the scheduled formulation under consideration is coming under more than one therapeutic category, the Average Price to Retailer of the scheduled formulation shall be calculated after taking into consideration the percentage reduction in Average Price to Retailer of other schedule formulations under all such therapeutic categories and the lowest average price to retailer shall be taken for calculating the ceiling price of the scheduled formulation under consideration. (2) Notwithstanding anything contained in this paragraph, where the price has been fixed and notified by the Government under the Drugs (Prices Control) Order, 1995 the provisions of sub-paragraph (1) shall not apply.

Previous and next

All provisions of Drugs (Prices Control) Order, 2013

Questions people ask

Is rule 6 of Drugs (Prices Control) Order, 2013 still in force?

No repeal of Drugs (Prices Control) Order, 2013 is recorded.